Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Analyst Color

Analyst Color

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Credit Suisse Cuts Applovin Price Target Factoring In Macro/Sector Headwinds

By Anusuya Lahiri
August 8, 3:02 PM
Credit Suisse analyst Stephen Ju cut the price target on Applovin Corp (NASDAQ:APP) to $80 from $100 and reiterated an Outperform ahead of…

APP

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • M&A
  • Price Target
  • Reiteration
  • Top Stories

Why These Pfizer Analysts Like The Global Blood Therapeutics Deal

By Wayne Duggan
August 8, 2:50 PM
Pfizer Inc. (NYSE: PFE) shares were trading lower Monday after the drugmaker announced a $5.4-billion bid to acquire blood disorder drugmaker Global Blood Therapeutics Inc (NASDAQ: GBT).

BHVN

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Mizuho Cuts Price Targets For These Fintech Companies Post Q2 Results

By Anusuya Lahiri
August 8, 2:41 PM
Mizuho analyst Dan Dolev updated his model and price targets for Fidelity National Information Services, Inc (NYSE:FIS), PayPal Holdings Inc (NASDAQ:PYPL), and Block Inc (NYSE:SQ)…

FIS

Read More
3 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Key Takeaways From Rosenblatt’s View On Chipmakers’ Earnings

By Anusuya Lahiri
August 8, 2:25 PM
Rosenblatt analyst Kevin Cassidy highlighted some key takeaways from last week's semiconductor earnings. Last week's earnings reports made it clear that companies exposed to the higher-end of markets saw their earnings holding up better. 

AAPL

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Reiteration
  • Small Cap

What Analysts Are Saying About Amazon’s $1.7B iRobot Acquisition Deal

By Priya Nigam
August 8, 12:39 PM
Amazon.com, Inc. (NASDAQ: AMZN) Friday announced plans to acquire iRobot Corporation (NASDAQ: IRBT) in an all-cash deal valued at $1.7 billion. Needham On Amazon’s iRobot Deal

AMZN

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Restaurants

Papa John’s Price Target Cut By Analyst As Inflation Pressure Persists

By Shivani Kumaresan
August 5, 4:06 PM
KeyBanc analyst Eric Gonzalez maintained an Overweight rating on Papa John’s International Inc (NASDAQ:PZZA) shares and lowered the price target to $105 from…

PZZA

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target
  • Reiteration

Ball Corp Hit With Downgrades, Price Target Cuts Post Q2 Results

By Akanksha Bakshi
August 5, 3:44 PM
Mizuho Securities analyst Christopher Parkinson lowered the price target for Ball Corp (NYSE:BALL) to $74 from $98 while maintaining the Neutral rating on…

BALL

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Movers
  • News
  • Price Target
  • Reiteration
  • Tech
  • Trading Ideas

This Cloud Software Provider Not Only Earned Large Customers In Q2, It Also Earned Price Target Hikes By Analyst

By Anusuya Lahiri
August 5, 3:09 PM
Cloudflare, Inc (NYSE: NET) clocked 54% revenue 

NET

Read More
2 minute read
  • Analyst Color
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks
  • Small Cap

This Analyst Cut Price Target On Canopy Growth After Q1 Earnings Release, Here’s Why

By Jelena Martinovic
August 5, 2:35 PM
On Friday, Canopy Growth Corporation (NASDAQ: CGC) reported a 19% year-over-year drop in net revenue to CA$110 million ($112.2 million) n

CGC

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Datadog’s Q2 Beat & Conservative Forecast Earns It Price Target Cuts From Analysts

By Anusuya Lahiri
August 5, 2:27 PM
Datadog, Inc (NASDAQ:DDOG) clocked second-quarter FY22 revenue growth of 74% year-on-year to $406.1 million, beating the consensus. Non-GAAP EPS of $0.24…

DDOG

Posts pagination

Previous 1 … 658 659 660 … 689 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service